{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:28:04Z","timestamp":1794472084414,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12325-020-01369-z","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:03:27Z","timestamp":1589616207000},"page":"2696-2709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination with Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase\u00a01, Open-Label, Randomized, Crossover Study"],"prefix":"10.1007","volume":"37","author":[{"given":"Lu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,16]]},"reference":[{"key":"1369_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.15420\/ecr.2016:34:2","volume":"12","author":"K Layne","year":"2017","unstructured":"Layne K, Ferro A. Antiplatelet therapy in acute coronary syndrome. Eur Cardiol. 2017;12:33\u20137.","journal-title":"Eur Cardiol"},{"key":"1369_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2125.1986.tb05195.x","volume":"21","author":"B Rosenkranz","year":"1986","unstructured":"Rosenkranz B, Fischer C, Meese CO, Frolich JC. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. Br J Clin Pharmacol. 1986;21:309\u201317.","journal-title":"Br J Clin Pharmacol"},{"key":"1369_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/00912700122010717","volume":"41","author":"OV Olesen","year":"2001","unstructured":"Olesen OV, Linnet K. Contributions of five human cytochrome P450 isoforms to the N-demethylation of clozapine in vitro at low and high concentrations. J Clin Pharmacol. 2001;41:823\u201332.","journal-title":"J Clin Pharmacol"},{"key":"1369_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/01.CIR.0000112577.69066.CB","volume":"109","author":"D Mukherjee","year":"2004","unstructured":"Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation. 2004;109:745\u20139.","journal-title":"Circulation"},{"key":"1369_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.amjmed.2003.12.041","volume":"117","author":"KA Eagle","year":"2004","unstructured":"Eagle KA, Kline-Rogers E, Goodman SG, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004;117:73\u201381.","journal-title":"Am J Med"},{"key":"1369_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.acvd.2009.08.009","volume":"102","author":"J-P Collet","year":"2009","unstructured":"Collet J-P, Aout M, Alantar A, et al. Real-life management of dual antiplatelet therapy interruption: the REGINA survey. Arch Cardiovasc Dis. 2009;102:697\u2013710.","journal-title":"Arch Cardiovasc Dis"},{"key":"1369_CR7","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa050522","volume":"352","author":"MS Sabatine","year":"2005","unstructured":"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179\u201389.","journal-title":"N Engl J Med"},{"key":"1369_CR8","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","volume":"294","author":"MS Sabatine","year":"2005","unstructured":"Sabatine MS, Cannon CP, Gibson CM, et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA. 2005;294:1224\u201332.","journal-title":"JAMA"},{"key":"1369_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494\u2013502.","journal-title":"N Engl J Med"},{"key":"1369_CR10","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","volume":"366","author":"ZM Chen","year":"2005","unstructured":"Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1607\u201321.","journal-title":"Lancet"},{"key":"1369_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11095-007-9434-x","volume":"25","author":"SH Haidar","year":"2008","unstructured":"Haidar SH, Davit B, Chen M-L, et al. Bioequivalence approaches for highly variable drugs and drug products. Pharm Res. 2008;25:237\u201341.","journal-title":"Pharm Res"},{"key":"1369_CR12","unstructured":"Reexamination report, Pharmaceuticals and Medical Devices Agency [Internet]. 2015 Jul p. 1\u201329. Available from: https:\/\/e-mr.sanofi.co.jp\/-\/media\/EMS\/Conditions\/eMR\/di\/interview\/complavin.pdf."},{"key":"1369_CR13","unstructured":"Examination report, Pharmaceuticals and Medical Devices Agency, The following are the results of the review by the Pharmaceuticals and Medical Devices Agency for the following drugs that have been submitted for approval. [Internet]. 2013 Aug p. 1\u201318. Available from: https:\/\/e-mr.sanofi.co.jp\/-\/media\/EMS\/Conditions\/eMR\/di\/interview\/complavin.pdf."},{"key":"1369_CR14","unstructured":"Abbreviates Study Clinical Study Report. An open-label, randomized, single-dose, two-sequence crossover relative bioavailability study of a tablet containing 75 mg of clopidogrel and 100 mg of aspirin versus the simultaneous administration of the separate formulations of the two drugs in Japanese healthy male subjects STUDY NUMBER: BDR11360, 2010;1\u201368 (Unpublished Manuscript)."},{"key":"1369_CR15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.clinthera.2013.05.015","volume":"35","author":"JA Jung","year":"2013","unstructured":"Jung JA, Kim T-E, Kim J-R, et al. The pharmacokinetics and safety of a fixed-dose combination of acetylsalicylic acid and clopidogrel compared with the concurrent administration of acetylsalicylic acid and clopidogrel in healthy subjects: a randomized, open-label, 2-sequence, 2-period, single-dose crossover study. Clin Ther. 2013;35:985\u201394.","journal-title":"Clin Ther"},{"key":"1369_CR16","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.2147\/DDDT.S109080","volume":"10","author":"H-K Choi","year":"2016","unstructured":"Choi H-K, Ghim J-L, Shon J, Choi Y-K, Jung JA. Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men. Drug Des Dev Ther. 2016;10:3493\u20139.","journal-title":"Drug Des Dev Ther"},{"key":"1369_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-199733010-00001","volume":"33","author":"RN Patnaik","year":"1997","unstructured":"Patnaik RN, Lesko LJ, Chen ML, Williams RL. Individual bioequivalence. Clin Pharmacokinet. 1997;33:1\u20136.","journal-title":"Clin Pharmacokinet"},{"key":"1369_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5414\/CPP43485","volume":"43","author":"KK Midha","year":"2005","unstructured":"Midha KK, Rawson MJ, Hubbard JW. The bioequivalence of highly variable drugs and drug products. Int J Clin Pharmacol Ther. 2005;43:485\u201398.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1369_CR19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1208\/s12248-012-9406-x","volume":"14","author":"BM Davit","year":"2012","unstructured":"Davit BM, Chen M-L, Conner DP, et al. Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the us food and drug administration. AAPS J. 2012;14:915\u201324.","journal-title":"AAPS J"},{"key":"1369_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1208\/s12248-016-9873-6","volume":"18","author":"L Tothfalusi","year":"2016","unstructured":"Tothfalusi L, Endrenyi L. An exact procedure for the evaluation of reference-scaled average bioequivalence. AAPS J. 2016;18:476\u201389.","journal-title":"AAPS J"},{"key":"1369_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/j.1552-4604.1995.tb04044.x","volume":"35","author":"IH Benedek","year":"1995","unstructured":"Benedek IH, Joshi AS, Pieniaszek HJ, King S-YP, Kornhauser DM. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers. J Clin Pharmacol. 1995;35:1181\u20136.","journal-title":"J Clin Pharmacol"},{"key":"1369_CR22","first-page":"313","volume":"35","author":"AD Ferguson","year":"2008","unstructured":"Ferguson AD, Dokainish H, Lakkis N. Aspirin and clopidogrel response variability. Tex Heart Inst J. 2008;35:313\u201320.","journal-title":"Tex Heart Inst J"},{"key":"1369_CR23","first-page":"477","volume":"09","author":"RC Dolores","year":"2017","unstructured":"Dolores RC, Antunes NJ, Moreno R, Di Vaio P, Magli E. Comparative bioavailability study of two 81\u00a0mg coated tablet formulations of acetylsalicylic acid in fasting healthy volunteers. J Bioequiv Bioavailab. 2017;09:477.","journal-title":"J Bioequiv Bioavailab"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01369-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01369-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01369-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T23:32:28Z","timestamp":1621121548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01369-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,16]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1369"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01369-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,16]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}